Teva Q3 Profit Rises More Than Expected on Strong Drug Sales
Teva said strong sales of three of its own drugs offset declines in copycat medicines, driving a higher-than-expected rise in third-quarter profit.
Israeli drugmaker Teva Pharmaceutical Industries TASE:TEVA, TASE:TEVA reported on Tuesday a higher-than-expected rise in third-quarter profit, helped by strong sales of a trio of its own drugs to offset declines in copycat medicines.